Anja Rosdahl

Artiklar i tidskrifter

• Angelin, M. , Sjölin, J. , Kahn, F. , Ljunghill Hedberg, A. , Rosdahl, A. , Skorup, P. , Werner, S. , Woxenius, S. & et al. (2023). Qdenga® - A promising dengue fever vaccine; can it be recommended to non-immune travelers?. Travel Medicine and Infectious Disease, 54.
• Hansson, K. , Rosdahl, A. , Insulander, M. , Vene, S. , Lindquist, L. , Gredmark-Russ, S. & Askling, H. H. (2020). Tick-borne encephalitis (TBE) vaccine failures: A ten-year retrospective study supporting the rationale for adding an extra priming dose in individuals from the age of 50 years. Clinical Infectious Diseases, 70 (2), 245-251.
• Rosdahl, A. , Herzog, C. , Frösner, G. , Norén, T. , Rombo, L. & Askling, H. H. (2019). Corrigendum to " An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression - A prospective, open-label, multi-center study" [Trav. Med. Infect. Dis. 21, January-February 2018, 43-50]. Travel Medicine and Infectious Disease, 27, 115-115.
• Rosdahl, A. , Herzog, C. , Frösner, G. , Norén, T. , Rombo, L. & Askling, H. H. (2018). An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression: A prospective, open-label, multi-center study. Travel Medicine and Infectious Disease, 21, 43-50.

Doktorsavhandlingar, sammanläggningar

• Rosdahl, A. (2023). The impact of viral vaccines in immunosuppressed and at-risk individuals. (Doctoral dissertation). (Sammanläggning) Örebro: Örebro universitet.

Manuskript

• Rosdahl, A. , Hellgren, F. , Norén, T. , Smolander, J. , Wopenka, U. , Loré, K. & Askling H., H. Cellular and humoral response to SARS-CoV-2 vaccine BNT162b2 in 2 adults with Chronic Kidney Disease stage 4 and 5.
• Hellgren, F. , Rosdahl, A. , Arcoverde Cerveira, R. , Lenart, K. , Ols, S. , Kwon, Y. , Kurt, S. , Delis, A. & et al. Prior infection modulates the early inflammatory response to mRNA vaccination.